Nicolas Lindegger

1.3k total citations
19 papers, 915 citations indexed

About

Nicolas Lindegger is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicolas Lindegger has authored 19 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicolas Lindegger's work include Cardiac electrophysiology and arrhythmias (6 papers), Ion channel regulation and function (5 papers) and HER2/EGFR in Cancer Research (5 papers). Nicolas Lindegger is often cited by papers focused on Cardiac electrophysiology and arrhythmias (6 papers), Ion channel regulation and function (5 papers) and HER2/EGFR in Cancer Research (5 papers). Nicolas Lindegger collaborates with scholars based in Switzerland, United States and Italy. Nicolas Lindegger's co-authors include Ernst Niggli, Andrew R. Marks, Robert S. Kass, Robert Barsotti, Graham C. R. Ellis‐Davies, Atsuya Momotake, Steven Reiken, Stephan E. Lehnart, Marco Mongillo and Bi-Xing Chen and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and The Journal of Physiology.

In The Last Decade

Nicolas Lindegger

19 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Lindegger Switzerland 9 511 489 201 141 106 19 915
David F. Steele Canada 22 969 1.9× 575 1.2× 239 1.2× 84 0.6× 65 0.6× 38 1.4k
Adele Stewart United States 16 504 1.0× 155 0.3× 171 0.9× 36 0.3× 82 0.8× 46 813
Christian Ried Germany 14 772 1.5× 227 0.5× 148 0.7× 18 0.1× 62 0.6× 19 1.1k
Xin Quan China 16 243 0.5× 67 0.1× 191 1.0× 50 0.4× 44 0.4× 46 731
Chowdhury S. Abdullah United States 13 393 0.8× 208 0.4× 78 0.4× 34 0.2× 49 0.5× 31 653
Anthony R. Soltis United States 12 418 0.8× 130 0.3× 54 0.3× 16 0.1× 53 0.5× 28 699
Mansoor Abdul United States 15 600 1.2× 105 0.2× 207 1.0× 12 0.1× 119 1.1× 24 919
Shiuhwei Chen United States 15 600 1.2× 101 0.2× 41 0.2× 84 0.6× 47 0.4× 23 1.3k
Daniel A. East United Kingdom 12 472 0.9× 93 0.2× 69 0.3× 41 0.3× 50 0.5× 12 732
Richa Aishwarya United States 11 340 0.7× 148 0.3× 73 0.4× 34 0.2× 40 0.4× 27 533

Countries citing papers authored by Nicolas Lindegger

Since Specialization
Citations

This map shows the geographic impact of Nicolas Lindegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Lindegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Lindegger more than expected).

Fields of papers citing papers by Nicolas Lindegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Lindegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Lindegger. The network helps show where Nicolas Lindegger may publish in the future.

Co-authorship network of co-authors of Nicolas Lindegger

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Lindegger. A scholar is included among the top collaborators of Nicolas Lindegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Lindegger. Nicolas Lindegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
DeBusk, Kendra, Nicolas Lindegger, Naomi Schwartz, et al.. (2022). Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases. Journal of Managed Care & Specialty Pharmacy. 28(6). 657–666. 2 indexed citations
2.
Lindegger, Nicolas, et al.. (2020). 308P Real-world outcomes among HER2+ metastatic breast cancer patients with brain metastases. Annals of Oncology. 31. S365–S366. 2 indexed citations
3.
Montemurro, Filippo, Peter Ellis, Antonio Antón, et al.. (2019). Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1. European Journal of Cancer. 109. 92–102. 78 indexed citations
6.
Montemurro, Filippo, Peter Ellis, Suzette Delaloge, et al.. (2017). Abstract P1-12-10: Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study. Cancer Research. 77(4_Supplement). P1–12. 19 indexed citations
7.
Puglisi, Fabio, Eva Ciruelos, Andreas Schneeweiß, et al.. (2017). Abstract P4-21-04: Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent/metastatic breast cancer (PERUSE). Cancer Research. 77(4_Supplement). P4–21. 1 indexed citations
9.
Lindegger, Nicolas, et al.. (2014). Macitentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, does not affect cardiac repolarization in healthy subjects. Pulmonary Pharmacology & Therapeutics. 29(1). 41–48. 7 indexed citations
10.
Cloutier, Gregory, et al.. (2014). Effects of a short‐term heavy resistance training in young and older adults for strength and body composition (1028.1). The FASEB Journal. 28(S1). 1 indexed citations
11.
Sidharta, Patricia N., et al.. (2013). Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment. The Journal of Clinical Pharmacology. 54(3). 291–300. 29 indexed citations
14.
Shan, Jian, Alexander Kushnir, Matthew J. Betzenhauser, et al.. (2010). Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. Journal of Clinical Investigation. 120(12). 4388–4398. 142 indexed citations
15.
Lindegger, Nicolas, Brian M. Hagen, Andrew R. Marks, W. Jonathan Lederer, & Robert S. Kass. (2009). Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine. Journal of Molecular and Cellular Cardiology. 47(2). 326–334. 37 indexed citations
16.
Lehnart, Stephan E., Marco Mongillo, Andrew M. Bellinger, et al.. (2008). Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. Journal of Clinical Investigation. 118(6). 2230–45. 307 indexed citations
17.
Lindegger, Nicolas, et al.. (2006). Altered Na+Channels Promote Pause-Induced Spontaneous Diastolic Activity in Long QT Syndrome Type 3 Myocytes. Circulation Research. 99(11). 1225–1232. 50 indexed citations
18.
Momotake, Atsuya, Nicolas Lindegger, Ernst Niggli, Robert Barsotti, & Graham C. R. Ellis‐Davies. (2005). The nitrodibenzofuran chromophore: a new caging group for ultra-efficient photolysis in living cells. Nature Methods. 3(1). 35–40. 185 indexed citations
19.
Lindegger, Nicolas & Ernst Niggli. (2005). Paradoxical SR Ca2+ release in guinea‐pig cardiac myocytes after β‐adrenergic stimulation revealed by two‐photon photolysis of caged Ca2+. The Journal of Physiology. 565(3). 801–813. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026